Azithromycin in coronavirus disease-19: What we know?

2Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

Abstract

Azithromycin (AZM) is a broad-spectrum antibiotic with anti-inflammatory and immunomodulatory properties. It is particularly used in chronic lung diseases including chronic obstructive pulmonary disease, asthma, interstitial lung diseases, bronchiectasis, and cystic fibrosis. AZM has not approved for the treatment of viral infections, but some study supported its antiviral activity. Recently, few studies are emphasized used AZM in combination with chloroquine/ hydroxychloroquine for the treatment of novel coronavirus disease-2019 (COVID-19). The present review highlighted uses, dosage, and adverse effects of AZM in COVID-19 based on available literature.

Cite

CITATION STYLE

APA

Agarwal, A. D. (2020). Azithromycin in coronavirus disease-19: What we know? Open Access Macedonian Journal of Medical Sciences, 8(T1), 92–96. https://doi.org/10.3889/oamjms.2020.4843

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free